Actinium Pharmaceuticals (ATNM) Q2 2026 Earnings

8MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.51
-0.39
-0.28
-0.16

Details

Expected EPS
-0.225
Actual EPS
-0.18
Surprise EPS
0.05
Surprise Percent
+20%

Description

Actinium Pharmaceuticals (ATNM) has reported earnings of -0.18 per share for Q2 2026.

0 Comments

Share your thoughts